2013
DOI: 10.1016/j.jep.2013.06.001
|View full text |Cite
|
Sign up to set email alerts
|

Mutagenicity and genotoxicity effects of Lignosus rhinocerotis mushroom mycelium

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(10 citation statements)
references
References 9 publications
0
10
0
Order By: Relevance
“…Earlier, Chen et al [8] reported that the mycelium of L. rhinocerotis did not provoke mutagenicity and genotoxicity; however, its cytotoxicity in mammalian cells was not evaluated. In light of this, extracts were screened for cytotoxicity against a panel of 21 mammalian cell lines using the MTT assay.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Earlier, Chen et al [8] reported that the mycelium of L. rhinocerotis did not provoke mutagenicity and genotoxicity; however, its cytotoxicity in mammalian cells was not evaluated. In light of this, extracts were screened for cytotoxicity against a panel of 21 mammalian cell lines using the MTT assay.…”
Section: Resultsmentioning
confidence: 99%
“…Abdullah et al [7] reported that solid-substrate fermentation of the mycelium on agroresidues yielded the fruiting body and sclerotium. In addition, liquid fermentation for the production of mycelium in bioreactors [8] as well as flasks under shaken [2] and static [9] conditions has been documented. Despite the advantages conferred by liquid fermentation for the production of fungal biomass and metabolites [10] , the economic potential of the mycelium and culture broth of L. rhinocerotis as sources of nutraceuticals has been overlooked due to continued reliance and emphasis on the naturally occurring sclerotium.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The genotoxic effects of L. rhinocerotis sclerotia were further evaluated by the bacterial reverse mutation or Ames test, the in-vitro chromosome aberration and in vivo mammalian erythrocyte micronucleus assays (Chen et al, 2013 ). At the concentration of the mycelium of L. rhinocerotis at 100 mg/mL (5 mg/plate) dose no mutagenic activity in the presence and absence of S9 metabolic activation system was observed in all the five Salmonella strains.…”
Section: Description Of L Rhinocerotismentioning
confidence: 99%
“…Artificially-cultivated L. rhinocerus is also an excellent replacement in the development of therapeutic items; for example, exopolysaccharides (EPS) isolated from mushroom mycelial biomass (MB) have pharmacological properties, such as immunomodulatory, anti-inflammatory, antibacterial, antiviral, and antioxidant properties 20 . Chen et al 21 discovered that L. rhinocerotis mycelium grown in SLF does not cause mutagenicity or genotoxicity. FDA standards, on the other hand, demand substantial proof of no hazard for commercial usage 21 .…”
Section: Introductionmentioning
confidence: 99%